Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$48.19 USD
-1.53 (-3.08%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $48.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/1/24 |
---|---|
Current Quarter | -1.57 |
EPS Last Quarter | -1.45 |
Last EPS Surprise | 11.59% |
ABR | 1.63 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.68 |
Next Year | -5.73 |
EPS (TTM) | -6.32 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.31M | 12.43M | 45.15M | 99.41M |
# of Estimates | 4 | 3 | 3 | 4 |
High Estimate | 14.91M | 16.94M | 57.92M | 160.76M |
Low Estimate | 8.30M | 8.80M | 34.60M | 63.80M |
Year ago Sales | 6.71M | 7.40M | 26.82M | 45.15M |
Year over Year Growth Est. | 53.65% | 68.01% | 68.31% | 120.20% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.57 | -1.48 | -2.68 | -5.73 |
# of Estimates | 6 | 3 | 6 | 6 |
Most Recent Consensus | -1.59 | -1.45 | -6.01 | -5.79 |
High Estimate | -1.45 | -1.45 | 11.76 | -4.31 |
Low Estimate | -1.69 | -1.54 | -6.89 | -6.87 |
Year ago EPS | -1.51 | -1.64 | -6.33 | -2.68 |
Year over Year Growth Est. | -3.97% | 9.76% | 57.66% | -113.68% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.57 | -1.48 | -2.68 | -5.73 |
7 Days Ago | -1.57 | -1.48 | -2.68 | -5.73 |
30 Days Ago | -1.57 | -1.48 | -2.68 | -5.73 |
60 Days Ago | -1.59 | -1.52 | -4.81 | -5.58 |
90 Days Ago | -1.63 | -1.56 | -5.02 | -5.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.57 | -1.48 | -2.68 | -5.73 |
Zacks Consensus Estimate | -1.57 | -1.48 | -2.68 | -5.73 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.45 | -1.72 | -1.64 | -1.51 | NA |
Estimate | -1.64 | -1.64 | -1.69 | -1.60 | NA |
Difference | 0.19 | -0.08 | 0.05 | 0.09 | 0.06 |
Surprise | 11.59% | -4.88% | 2.96% | 5.63% | 3.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more